ARCHIVES

Interview: A Conversation with Robert Carlson

This article is from The Cancer Letter archive.

Vol. 38 No. 37 | October 5, 2012

Download PDF Visit The Full Archive

Related Articles

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

March 2, 2001

SEC Investigating Bristol-Myers’ Sales Statements

July 12, 2002

Pittsburgh Investigates Use of Resources in Anonymous Mailing To Researchers

April 29, 1994

BCDDP Follow Up To Cost $1.6 Million annually For Five Years Okayed; Limited To 59,000 Women

November 3, 1978

Senate Appropriations Committee Slashes NCI Funds By $25 Million

August 18, 1978

Kimes, Lenfant, To Retire

July 11, 2003